Rexulti 0.25 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FJK41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,088
Award facts
- Contract value 100% obligated
- $18,087.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,087.93 to AmerisourceBergen Drug Corp for the supply of REXULTI (brexpiprazole) 0.25 mg tablets in quantities of 30 on August 13, 2025. This firm fixed-price, non-set-aside contract was competitively awarded and is scheduled for completion by August 14, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. REXULTI is an atypical antipsychotic medication used in the treatment of schizophrenia and major depressive disorder, representing a critical pharmaceutical supply for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp has demonstrated substantial capability in fulfilling specialized medication requirements for the Defense Health Agency and other government healthcare systems. The company's extensive portfolio of federal contract awards reflects its role as a critical vendor within the military's medical supply chain for diverse pharmaceutical products spanning multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJK41?
SPE2DB25FJK41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FJK41 worth?
The government has obligated $18,088 on SPE2DB25FJK41.
Is contract SPE2DB25FJK41 an order under another contract?
Yes. SPE2DB25FJK41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJK41 competed?
The extent of competition for SPE2DB25FJK41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award